Avelumab in Refractory Testicular Germ Cell Cancer.

NCT03403777 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER_GOV

Sponsor class

Conditions

Testicular Neoplasms
Neoplasms, Germ Cell and Embryonal
Neoplasms
Testicular Diseases
Gonadal Disorders
Antineoplastic Agents
Molecular Mechanisms of Pharmacological Action

Interventions

DRUG: Avelumab

Sponsor

National Cancer Institute, Slovakia

Collaborators

[object Object]